An unbiased lncRNA dropout CRISPR-Cas9 screen reveals RP11-350G8.5 as a novel therapeutic target for multiple myeloma.
Grillone K, Ascrizzi S, Cremaschi P, Amato J, Polerà N, Croci O, Rocca R, Riillo C, Conforti F, Graziano R, Brancaccio D, Caracciolo D, Alcaro S, Pagano B, Randazzo A, Tagliaferri P, Iorio F, Tassone P.
Grillone K, et al. Among authors: randazzo a.
Blood. 2024 Oct 17;144(16):1705-1721. doi: 10.1182/blood.2023021991.
Blood. 2024.
PMID: 39158066
Free PMC article.